We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




PCR Technology Helps Detect Food Pathogens and Spoilage Microorganisms

By Labmedica staff writers
Posted on 28 Apr 2008
Advanced real-time polymerase chain reaction (PCR) technology is increasingly being used in the rapid detection of food pathogens and spoilage microorganisms. More...
The technique allows an exponential amplification of DNA from just a few to more than a billion copies in less than one hour. This enables a significant reduction in the time taken to achieve results in comparison with conventional cultivation techniques.

The increasing use of rapid food safety testing is receiving more and more attention. The major reason for this key trend is that the food industry requires quick and accurate results. Traditional microbiological methods are relatively slow and sometimes inaccurate in comparison to new molecular biologic techniques. Fast and reliable detection systems are therefore the method of choice.

Under its foodproof brand, Biotecon Diagnostics (Potsdam, Germany) has developed real-time PCR detection kits for Enterobacteriaceae plus Enterobacter sakazakii (new), Salmonella, Listeria, Campylobacter, Escherichia coli O157, among others. The range also comprises a unique kit for the screening of beer spoilage organisms as well as genetically modified organism (GMO) testing kits.

To enhance the worldwide launch of its food safety testing systems, Biotecon Diagnostics has formed a strategic marketing alliance with the globally operating Merck (Darmstadt, Germany). Merck sells the foodproof range that has been available in almost all countries of the world since January 1, 2008. More products are expected to be forthcoming later in the year.

Dr. Kornelia Berghof-Jaeger, CEO, Biotecon Diagnostics said, "In this alliance, Merck KGaA will contribute significantly through its expertise in microbiology and its excellent customer relationships. Jointly we are able to fulfill the customer needs by introducing this new technology to the food safety testing labs around the world.”

"For Merck KGaA, this partnership means a consequential advancement in order to underline our leading position in specialty chemicals, especially in analytical reagents and test kits,” commented Wolfgang E. Schmidt, head of microbiology, hygiene, and microscopy at Merck KGaA. "Our philosophy of highest quality demands is perfectly met by the solutions offered by Biotecon Diagnostics.”


Related Links:
Biotecon Diagnostics
Merck

Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
ESR Analyzer
miniiSED™
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.